ARUP Newsroom

ARUP Consult offers expert guidance on laboratory testing for influenza, RSV, and COVID-19, helping clinicians order the right tests at the right time.

ARUP Healthcare Advisory Services can help labs prepare for the quality management system requirements in the FDA’s final rule on laboratory-developed tests, despite the rule’s uncertain future.

ARUP supported 15 families resettling in Utah through the International Rescue Committee’s Light One Candle initiative with donations that included toys, toiletries, and TVs.

ARUP has launched a new assay for the detection and subtyping of influenza A (H5) virus, which will expand the national capacity to detect the current outbreak of highly pathogenic avian influenza A…

Benjamin Bradley, MD, PhD, compared the H5N1 outbreak to COVID-19, highlighting the preparedness of labs and the CDC’s proactive approach during a media briefing.

ARUP employee Eric Allen started donating blood in 1989 to overcome his fear of blood. Decades later, he has now donated platelets 450 times.

Next generation sequencing (NGS) testing detects UBA1 gene mutations, which are essential for the diagnosis of VEXAS syndrome and concurrent hematologic neoplasms.

ARUP medical directors will present key hematopathology research at the 66th ASH Annual Meeting, including developments in systemic mastocytosis treatment and testing for myeloid malignancy mutations.